Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
deals
fda
3
×
investing
3
×
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
takeda pharmaceutical
3
×
boulder/denver blog main
boulder/denver top stories
cancer
cystic fibrosis
detroit blog main
detroit top stories
duchenne muscular dystrophy
human microbiome
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
What
bio
roundup
ahead
alliance
analytics
asco
biofourmis
branded
bristol
buy
calls
changing
choices
color
commissioner
consumers
costly
counterweight
crispr
data
days
devices
digital
drugs
elevatebio
employs
fda
generic
globally
graft
growing
hauls
help
hours
kudos
leaves
medications
million
myers’s
notifying
Language
unset
Current search:
roche
×
fda
×
investing
×
" takeda pharmaceutical "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More